Year None20212020201920182017 Aug 10, 2021 Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies Aug 03, 2021 Tango Therapeutics to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference Apr 14, 2021 Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies Mar 24, 2021 Tango Therapeutics Appoints Mace Rothenberg, MD, and Lesley Ann Calhoun, CPA, to Board of Directors
Aug 10, 2021 Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies
Aug 03, 2021 Tango Therapeutics to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference
Apr 14, 2021 Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies
Mar 24, 2021 Tango Therapeutics Appoints Mace Rothenberg, MD, and Lesley Ann Calhoun, CPA, to Board of Directors
